Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00183625 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients

StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Lead sponsor: National Institute of Mental Health (NIMH) to University of California, Los Angeles Results first posted: Jun 10, 2015 · Enrollment target: 160 to 107 · Primary endpoints: 2 to 1 · 7 morev4 Show 10 more changesShow less
    • Results first posted: Jun 10, 2015
    • Enrollment target: 160 to 107
    • Primary endpoints: 2 to 1
    • Primary completion date: Jun 2005
    • Completion date: Sep 2005 to Sep 2006
    • Interventions: Individual Placement and Support (Behavioral), Olanzapine (Drug), Risperidone (Drug), Social Skills Training (Behavioral) to Individual Placement and Support (Supported Employment) (Behavioral), Olanzapine (Drug), Risperidone (Drug), Social Skills Training…
    • Collaborators expanded, about 11 words
    • Study arms: 0 to 4
    • Secondary endpoints expanded, about 3 words
    • Study title shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv3
  4. Primary endpoints: 1 to 2 Trial status: Active, Not Recruiting to Completed · Eligibility criteria expanded, about 19 words · Secondary endpoints shortened, about 11 words · 3 morev2 Show 6 more changesShow less
    • Trial status: Active, Not Recruiting to Completed
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints shortened, about 11 words
    • Study sites revised (2)
    • Study description shortened, about 3 words
    • Study title expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will compare employment support with behavioral skills training to employment support alone in schizophrenia patients taking either risperidone or olanzapine to determine which is more effective in helping the patients maintain a job.
Trial Details
NCT Number NCT00183625
Lead Sponsor University of California, Los Angeles
Collaborators: National Institute of Mental Health (NIMH), US Department of Veterans Affairs
Conditions Schizophrenia
Enrollment 107 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov